Search results
Found 1149 matches for
The collective force of cancer research, outreach and care across the city of Oxford, translating discoveries into better care for cancer patients.
OxCITE
OxCITE (Oxford Cancer Immunotherapy Toxicity and Efficacy) is a cohort study initiated in November 2015 with samples collected within the Oxford Radcliffe Biobank. It explores the relationships between patients’ genetics, immune systems, and response to checkpoint immunotherapy.
LynchVax
A Cancer Prevention Vaccine Programme.
Oxford CRUK Clinical Trials Unit Collaboration
Launched in 2023, the Oxford CRUK Clinical Trials Unit (CTU) is the first dedicated unit in the UK aiming to deliver a a portfolio of precision prevention and early detection cancer trials. It is a partnership between Oxford’s Oncology Clinical Trials Office (OCTO) and the Primary Care Clinical Trials Unit (PC-CTU).
COMBATcancer
‘COMBATcancer’ (Combined Molecular Analysis of Blood and Tissue in cancer) is a programme initiated by the CRUK Oxford Centre in 2023.
Oesophagogastric Cancer Centre of Excellence
In establishing our Oesophageal Cancer Centre of Excellence, we have cultivated an Oxford-based community of clinicians to take the field forward.
Oxford Cancer Vaccine Hub
The Oxford Cancer Vaccine Hub facilitates innovation from multiple research groups and aims to achieve transformative benefits in the treatment of multiple cancer types, as well as preventing cancer development/recurrence in people at clinically defined higher risk.
Liver Cancer Centre of Excellence
The Liver Cancer Centre of Excellence leverages Oxford’s internationally renewed multi-disciplinary cancer expertise and world-class data science prowess to accelerate the translation of liver cancer research into the clinic.
SCAN
The award-winning Suspected Cancer Pathway designed to accelerate cancer diagnoses in patients with non-specific symptoms, now being implemented nationally and underpinning several research projects.
SYMPLIFY
The SYMPLIFY study will evaluate the revolutionary multi-cancer blood test Galleri, for future implementation in the NHS.
SAIL
Scientific Advances in Infant Acute Lymphoblastic Leukaemia (SAIL) – Establishing an Interactive National Database
DART
Using data collected by the NHS Lung Health Check programme to develop and validate Artificial Intelligence to more accurately and quickly diagnose lung disease
National Cancer Imaging Translational Accelerator (NCITA)
A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers
MAGE Cancer Vaccine (VTP-600)
A novel cancer immunotherapy vaccine based on new & unique surface molecules that Oxford researchers have discovered.
LUD2015-005
A multi-disciplinary clinical trial and research project investigating new immunotherapy drug opportunities in oesophageal cancer.
AI-REAL
A global health project, bringing next generation technologies to Tanzania and Uganda, and improving the in-country testing process for EBV lymphomas.
ARCADIAN
A follow-on clinical trial investigating antimalarial drug Atovaquone as a method to improve the impact of chemoradiotherapy
DeLIVER
A research study into methods of early detection of hepatocellular liver cancer, using novel blood tests, imaging technologies and next generation sequencing to identify new biomarkers and underlying mechanisms that can lead to cancer progression
OxPLoreD
An observational cohort study to identify early detection markers for malignant blood cancers such as CLL and MGUS